Neurogene (NGNE) Non Operating Income (2013 - 2026)

Neurogene has reported Non Operating Income for 14 years, with the latest figure at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 26.19% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (up 36.55% YoY), and the FY2025 full-year result was $13.0 million, up 73.93% from the prior year.
• Non Operating Income for Q1 2026 stood at $2.4 million, down from $2.8 million in the prior quarter.
• The five-year high for Non Operating Income was $19.3 million in Q4 2023, with the low at -$22000.0 in Q3 2022.
• Historically, Non Operating Income has averaged $2.8 million across 5 years, with a median of $2.0 million in 2024.
• The largest YoY upside for Non Operating Income was 192910.0% in 2023 against a maximum downside of 1500.0% in 2023.
• Neurogene's Non Operating Income stood at -$10000.0 in 2022, then surged by 192910.0% to $19.3 million in 2023, then slumped by 89.64% to $2.0 million in 2024, then soared by 39.84% to $2.8 million in 2025, then slipped by 13.56% to $2.4 million in 2026.
• The last three Non Operating Income figures came in at $2.4 million (Q1 2026), $2.8 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.